The tissue-resident marker CD103 on peripheral blood T cells predicts responses to anti-PD-1 therapy in gastric cancer
Yohei Nose, Takuro Saito, Kei Yamamoto, Kotaro Yamashita, Koji Tanaka, Kazuyoshi Yamamoto, Tomoki Makino, Tsuyoshi Takahashi, Atsunari Kawashima, Miya Haruna, Michinari Hirata, Azumi Ueyama, Kota Iwahori, Taroh Satoh, Yukinori Kurokawa, Hidetoshi Eguchi, Yuichiro� Doki, Hisashi Wada
Topics & Concepts
NivolumabMedicineCD8Cytotoxic T cellCancerPopulationImmune systemInternal medicineImmunologyImmunotherapyBiologyEnvironmental healthBiochemistryIn vitroCancer Immunotherapy and BiomarkersGastric Cancer Management and OutcomesCholangiocarcinoma and Gallbladder Cancer Studies